These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9856586)

  • 1. Selective plasminogen binding: cysteinyl-lysine-dextran protein interactions.
    Warkentin PH
    Biomaterials; 1998 Oct; 19(19):1753-61. PubMed ID: 9856586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and activation of plasminogen at the surface of Staphylococcus aureus. Increase in affinity after conversion to the Lys form of the ligand.
    Kuusela P; Saksela O
    Eur J Biochem; 1990 Nov; 193(3):759-65. PubMed ID: 1701146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.
    Wiman B; Lijnen HR; Collen D
    Biochim Biophys Acta; 1979 Jul; 579(1):142-54. PubMed ID: 157166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen interactions with immobilized fibrinogen.
    Adelman B; Quynn P
    Thromb Haemost; 1989 Dec; 62(4):1078-82. PubMed ID: 2617455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of plasminogen and fibrinogen with model silica glass surfaces: adsorption from plasma and enzymatic activity studies.
    Woodhouse KA; Weitz JI; Brash JL
    J Biomed Mater Res; 1994 Apr; 28(4):407-15. PubMed ID: 8006045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
    Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of fibrinolytic system proteins with lysine-containing surfaces.
    McClung WG; Clapper DL; Anderson AB; Babcock DE; Brash JL
    J Biomed Mater Res A; 2003 Sep; 66(4):795-801. PubMed ID: 12926031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine-derivatized polyurethane as a clot lysing surface: conversion of adsorbed plasminogen to plasmin and clot lysis in vitro.
    McClung WG; Clapper DL; Hu SP; Brash JL
    Biomaterials; 2001 Jul; 22(13):1919-24. PubMed ID: 11396898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-resistant and fibrinolytic polyurethane surfaces.
    Wu Z; Chen H; Liu X; Brash JL
    Macromol Biosci; 2012 Jan; 12(1):126-31. PubMed ID: 21998081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Binding of Glu-plasminogen by fibrinogen and byproducts of its proteolysis].
    Grinenko TV; Tret'iachenko VG; Skomorovskaia EV; Kudinov SA
    Biokhimiia; 1989 Feb; 54(2):213-20. PubMed ID: 2525932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine-PEG-modified polyurethane as a fibrinolytic surface: Effect of PEG chain length on protein interactions, platelet interactions and clot lysis.
    Li D; Chen H; Glenn McClung W; Brash JL
    Acta Biomater; 2009 Jul; 5(6):1864-71. PubMed ID: 19342321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adsorption of plasminogen from human plasma to lysine-containing surfaces.
    McClung WG; Clapper DL; Hu SP; Brash JL
    J Biomed Mater Res; 2000 Mar; 49(3):409-14. PubMed ID: 10602074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Complement Binding and Inhibitory Protein CbiA of
    Nguyen NTT; Röttgerding F; Devraj G; Lin YP; Koenigs A; Kraiczy P
    Front Cell Infect Microbiol; 2018; 8():23. PubMed ID: 29456970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of activity assays for tissue plasminogen activator.
    Tang JC; Li S; McGray P; Vecchio A
    Ann N Y Acad Sci; 1984; 434():536-40. PubMed ID: 6441502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features of the interaction of Glu- and Lys-forms of plasminogen with native and partially hydrolyzed fibrin].
    Grinenko TV; Skomorovskaia EV; Kudinov SA; Zolotareva EN
    Biokhimiia; 1992 May; 57(5):728-37. PubMed ID: 1322196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin.
    Ryan TJ; Keegan MC
    Biochim Biophys Acta; 1985 Aug; 830(2):187-94. PubMed ID: 3160389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A battery of monoclonal antibodies that induce unique conformations to evolve cryptic but constitutive functions of plasminogen.
    Madoiwa S; Arai K; Ueda Y; Ishizuka M; Mimuro J; Asakura S; Matsuda M; Sakata Y
    J Biochem; 1997 Feb; 121(2):278-87. PubMed ID: 9089401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.
    Lijnen HR; Van Hoef B; Matsuo O; Collen D
    Biochim Biophys Acta; 1992 Jan; 1118(2):144-8. PubMed ID: 1730031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.